NLRP3 and columnar cell hyperplasia of the breast: Vitexin treatment reversed CCH-induced downregulation of Epac1, Epac2, Rap1, and phospho-ERK and suppressed inflammation via inhibition of the NLR family pyrin domain containing 3 (NLRP3) inflammasome.